Ledger.Open graph →
SEC Form D · filed February 8, 2021

Interline Therapeutics, Inc

Offering
$10.1M
Sold
$10.1M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

James Tananbaum · Philadelphia, PADirectorZachary Sweeney · San Francisco, CAExec · DirectorVikram Bajaj · South San Francisco, CADirectorJames Tananbaum · Fort Washington, PADirectorVikram Bajaj · South San Francisco, CADirectorZachary Sweeney · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗